Optiscan
Optiscan Imaging Ltd is an Australian medtech company that develops and manufactures proprietary confocal laser endomicroscopy systems for real-time, slide-free, biopsy-free single-cell imaging, serving hospitals, pathology labs, veterinary practices and research institutions across multiple global markets.
- Company typePublic
- Founded1994
- HeadquartersMulgrave, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Optiscan does
Optiscan Imaging Ltd is an Australian medical technology company founded in 1994 that develops and manufactures proprietary confocal laser endomicroscopy systems enabling real-time, non-destructive, in vivo digital imaging at single-cell resolution (0.55µm). The company, headquartered in Melbourne with a manufacturing facility producing approximately 50 systems per year and a US subsidiary in Rochester, Minnesota, sells a portfolio of five products (InVue for precision surgery, InForm for digital pathology, InVivage for dental/oral applications, ViewnVivo for preclinical life sciences research, and InSpecta for veterinary medicine) to hospitals, pathology laboratories, veterinary practices, dental clinics, and academic research institutions across Australia, the United States, Europe, and Asia Pacific. Revenue is generated through capital equipment sales (quote-based multi-year enterprise contracts), recurring software and AI solutions including cloud-based telepathology streaming co-developed with Prolucid Technologies, and ongoing service and support contracts. The company maintains ISO 13485:2016 certification and is pursuing FDA regulatory clearance for US market entry while leveraging co-development partnerships with Mayo Clinic (robotic surgery imaging), Carl Zeiss Meditec (CONVIVO for neurosurgery), and Monash University (next-generation GI endomicroscope).
Optiscan firmographics
Firmographics- Name
- Optiscan
- Legal name
- Optiscan Imaging Ltd
- Website
- https://optiscan.com
- Company type
- Public
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Optiscan Imaging Ltd is an Australian medtech company that develops and manufactures proprietary confocal laser endomicroscopy systems for real-time, slide-free, biopsy-free single-cell imaging, serving hospitals, pathology labs, veterinary practices and research institutions across multiple global markets.
- Ownership category
- akta.pro rank
Optiscan industry classification
Industry- Product category
- Medical Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
- akta.pro secondary industries
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Imaging Equipment & Accessories (X-ray, Ultrasound, Endoscopy) (HLAMAFAC), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM)
Keywords
Where Optiscan is headquartered
LocationHeadquarters
- HQ city
- Mulgrave
- HQ country
- Australia
- HQ region
- Oceania
Offices5 records
Markets served
Optiscan business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Medical Imaging Device Sales: Sale of proprietary confocal endomicroscopic imaging systems including InVue, InForm, InVivage, InSpecta, and ViewnVivo devices for medical, veterinary, and life sciences applications
- Software and AI Solutions: Cloud-based telepathology streaming services and AI-powered image analysis software-as-a-medical-device co-developed with Prolucid Technologies for digital pathology workflows
- Service and Support: Applications support, customer support, and ongoing maintenance services for imaging systems
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/B2B medical device pricing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Optiscan product offering
Product offeringCore offering
Optiscan develops, manufactures, and sells proprietary confocal endomicroscopy imaging systems for medical, veterinary, dental, and life sciences applications. Its product portfolio includes InVue (precision surgery), InForm (digital pathology), InVivage (intra-oral), ViewnVivo (preclinical research), and InSpecta (veterinary), all built on a miniaturized fiber optic platform delivering real-time, biopsy-free, slide-free, in-vivo imaging at single-cell resolution. The company complements hardware sales with AI-powered image analysis software, cloud-based telepathology streaming, and applications/service support.
Product overview
Optiscan offers a portfolio of five distinct real-time confocal endomicroscopic imaging products serving different market segments. The portfolio includes: InVue (precision surgery), InForm (digital pathology), InVivage (dental/oral), ViewnVivo (preclinical research), and InSpecta (veterinary medicine). All products share the core patented technology platform enabling real-time, slide-free, biopsy-free, in-vivo cellular imaging at 0.55μm resolution. The platform integrates hardware devices with software capabilities including AI-powered image analysis, telepathology streaming, and PACS connectivity.
Differentiator
Problem solved
Functional benefit
Products and services
- Optiscan InVue A microscopic medical imaging device for precision surgery using confocal laser endomicroscopy with a fiber-optic probe for real-time, in-vivo visualization of internal tissue microstructure. Designed for breast, head, neck, and other surgeries, placing digital pathology directly in surgeons' hands for intraoperative decision-making.
- Optiscan InForm A next-generation digital pathology imaging device providing real-time, slide-free cellular imaging at point of tissue collection, eliminating the need for traditional slide preparation and tissue processing. DICOM-compatible and PACS-enabled for laboratory and surgical environments.
- Optiscan InVivage An intra-oral digital endomicroscope providing virtual histology of the oral cavity for identification of tissue disease, monitoring of mucosal lesions, and mapping of surgical margins. Features a miniaturized 4mm diameter handheld probe, ORIS operating system for dental workflow, and DICOM-compatible/PACS-enabled image transmission.
- Optiscan ViewnVivo A life-sciences endomicroscope for research applications providing high-resolution, portable, flexible intravital fluorescence confocal imaging for preclinical and translational research. Designed for in-vivo cellular imaging in animal models and tissue culture with Z-stack capability up to 400 microns depth.
- Optiscan InSpecta A veterinary-first digital microscopic imaging device delivering real-time, cellular-level imaging at point of care without slides, tissue processing, or lab delays. Compact, portable system with adjustable imaging depth up to 150µm, designed for species-agnostic use in veterinary practices.
Quantifiable outcome
- Real-time imaging capability eliminating hours to days of traditional pathology turnaround
- +2 more outcomes
Companies that use Optiscan
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles4 records
Optiscan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability3 records
Feature4 records
Optiscan partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and secondary.
- Australian Clinical LabscoreCollaboration Agreement with Australia's leading private pathology provider to support deployment, evaluation and testing of InForm digital pathology platform.
- Long Grove PharmaceuticalscoreUS pharmaceutical partnership to support FDA submissions, integrating Optiscan's imaging technology with drug development and clinical trial processes.
- University of Minnesota College of Veterinary MedicinecoreCollaboration with leading US veterinary teaching and research institution to advance clinical evaluation of InSpecta and explore new veterinary applications for real-time imaging technology.
- Monash UniversitycoreAgreement to progress project for scope-agnostic GI flexible endomicroscope and next-generation AI technology. Original technology was created at Monash University.
- Mayo CliniccoreKnow-How Agreement for development of a digital endomicroscopic imaging system designed for robotic-assisted surgery. Collaboration combines Optiscan's engineering expertise with Mayo Clinic's robotic surgery and patient care capabilities. Initial focus on breast cancer surgery with all key engineering milestones completed. Agreement extended until 12 August 2026.
- J&H Technology Co LtdsecondaryExclusive pre-clinical distributor for Taiwan, distributing ViewnVivo products for life sciences research applications.
- Prolucid TechnologiescoreCanadian-based software engineering firm engaged to co-develop Optiscan's cloud-based telepathology streaming service and AI software-as-a-medical-device for the endomicroscopy product suite.
- Capgemini (formerly D+I)secondaryWorking with Capgemini's Design Industry team to co-develop next generation endomicroscopic imaging platform and device portfolio.
- Carl Zeiss MediteccoreCONVIVO collaboration resulting in live microscopic imaging technology for neurosurgery. Carl Zeiss Meditec commercializes Optiscan's confocal imaging technology customized for specific medical applications.
- Royal Melbourne HospitalcoreClinical studies with Australia's leading public teaching hospital to evaluate InVue and InForm devices in breast cancer surgery.
- St John of God Murdoch HospitalsecondaryClinical trial as part of broader clinical program evaluating imaging technologies in head and neck cancer surgery.
- Arizona Animal HospitalsecondaryCollaboration with leading US companion animal practice for clinical evaluation and early commercial introduction of InSpecta veterinary device.
- University Medical Center MainzsecondaryPre-clinical gastrointestinal study supporting evaluation of endomicroscopy technology in GI applications.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Optiscan competitors and assessment
Company assessmentOthers
- Hamamatsu Photonics: Specialist in optical/photonic components and digital slide scanners. Adjacent competitor/supplier in optical imaging and pathology workflows relevant to confocal endomicroscopy.
Broad incumbents
- Leica Microsystems (Danaher): Danaher-owned microscopy and pathology imaging company. Competes with Optiscan's ViewnVivo life-science endomicroscope and broader pathology imaging solutions.
- Olympus Corporation: Global leader in endoscopy systems. Competes with Optiscan's endoscopic imaging across GI and surgical endoscopy, and offers integrated digital/AI workflows at much larger scale.
- Stryker: Broad surgical-imaging and equipment incumbent with extensive neurosurgery, ENT, and orthopedic visualization portfolios. Competes with Optiscan's intraoperative and precision-surgery applications.
- Philips (Digital Pathology): Large incumbent in digital pathology (IntelliSite) and clinical imaging. Competes with Optiscan's InForm digital pathology platform at the hospital-IT integration level.
- Bruker Corporation: Life-science and microscopy instrumentation vendor with preclinical imaging products overlapping ViewnVivo's translational research use case.
Direct peers
- Carl Zeiss Meditec: Strategic partner that already commercializes Optiscan's CONVIVO technology in neurosurgery, and a broad incumbent in intraoperative/surgical microscopy and ophthalmic devices. Overlapping product portfolio in surgical imaging and digital pathology.
- Mauna Kea Technologies (Cellvizio): Paris-based pioneer of confocal laser endomicroscopy (Cellvizio). Most direct comparable to Optiscan's core technology platform across GI, pulmonary, and surgical applications; same customer base of specialists seeking in vivo cellular imaging.
- 3DHISTECH (3DHistech Ltd.): Hungarian vendor of digital pathology scanners and workflow software. Direct competitor in slide-free/slide-based pathology workflows targeted by Optiscan InForm.
Emerging players
- Eleméd Technologies (POCUS / point-of-care ultrasound for vet): Point-of-care imaging providers in veterinary settings (e.g., GE HealthCare veterinary ultrasound, Clarius, etc.). Compete with InSpecta for veterinary point-of-care diagnostic imaging budgets, though using a different modality.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Optiscan social profiles
Digital presenceOptiscan compliance and trust
Trust signalCompliance4 records
Optiscan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Optiscan leadership team
Management profileNumber of profiles
Profiles17 records
Optiscan subsidiaries and ownership
Company hierarchySubsidiaries1 record
Optiscan funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Optiscan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Optiscan
What does Optiscan do?
Optiscan develops, manufactures, and sells proprietary confocal endomicroscopy imaging systems for medical, veterinary, dental, and life sciences applications. Its product portfolio includes InVue (precision surgery), InForm (digital pathology), InVivage (intra-oral), ViewnVivo (preclinical research), and InSpecta (veterinary), all built on a miniaturized fiber optic platform delivering real-time, biopsy-free, slide-free, in-vivo imaging at single-cell resolution. The company complements hardware sales with AI-powered image analysis software, cloud-based telepathology streaming, and applications/service support.
Is Optiscan a public or private company?
Optiscan is a public company. It is classified as public and is currently operating.
When was Optiscan founded?
Optiscan was founded in 1994. It employs 11 to 50 people.
Where is Optiscan based?
Optiscan is headquartered in Mulgrave, Australia, in the Oceania region.
How does Optiscan make money?
Three revenue lines are on record. Medical Imaging Device Sales are the primary driver. The others are software and AI Solutions and service and Support.
Who are Optiscan's main competitors?
Hamamatsu Photonics is listed as an others. Broad incumbents are Leica Microsystems (Danaher), Olympus Corporation, Stryker, Philips (Digital Pathology) and Bruker Corporation. Direct peers are Carl Zeiss Meditec, Mauna Kea Technologies (Cellvizio) and 3DHISTECH (3DHistech Ltd.). Eleméd Technologies (POCUS / point-of-care ultrasound for vet) is listed as an emerging player.
Does Optiscan have an API?
No public API is recorded for Optiscan.
What industry is Optiscan in?
Optiscan's product category is Medical Imaging Devices. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 334510 and its SIC code is 3841.